Alnylam Pharmaceuticals | مبيعات



Sales تغيير تاريخ
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Amgen USD 9.18B 1.03B 2025-06
Arrowhead Research USD 27.77M 514.94M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
Moderna USD 142M 34M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Novartis USD 13.56B 386M 2024-12
PTC Therapeutics USD 178.9M 11.1M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Takeda JPY 1.11T 60B 2025-06
Tectonic Therapeutic 0 0 2024-12
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06
Xencor USD 43.61M 10.88M 2025-06


Alnylam Pharmaceuticals مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.